Status Regarding Novo Nordisk A/S's Holding Of Its Own Shares (30 September 2017)

Published: Oct 02, 2017

Bagsværd, Denmark, 2 October 2017 - In continuation of the company's announcements dated 3 May 2017 and 9 August 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 September 2017 owned 41,621,013 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 8,324,203 or 1.7% of the total share capital.

In the third quarter of 2017 a total of 14,842,082 B shares were repurchased, and 3,418 B shares were disposed to employees in connection with employee incentive programmes.

Further information

Media:
Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau@novonordisk.com
Investors:
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Hanna Ögren +45 3079 8519 haoe@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Christina Kjær +45 3079 3009 cnje@novonordisk.com
Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com

Company announcement No 76 / 2017

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/24eb336d-84a7-4c0e-a320-1d7402746b58

Back to news